Spark Biomedical Launches Clinical Trial to Validate its Auricular Neurostimulation Device for Opioid Withdrawal Relief

Spark Biomedical clinical trial
The Phoenix system is worn over the ear for up to 5 days, and may help reduce opioid withdrawal symptoms (Image credit: Phoenix study, Spark Biomedical)
Spark Biomedical, a Texas-based neurostimulation device company developing solutions for opioid withdrawal, announced open patient enrollment in their clinical trial to validate the company’s auricular neurostimulation device for opioid withdrawal. […]
To access this page, watch the live streams and videos on-demand, please register free of charge to the WT | Wearable Technologies COMMUNITY.
Previous articleActLight’s Ultra-Small Size and Low Power Consumption Make It Ideal for Heart Rate Monitoring in Hearables
Next articleIntertek Launches First Ever Cybersecurity Certification Program with Continuous Vulnerability Monitoring
Cathy Russey () is Online Editor at WT | Wearable Technologies and specialized in writing about the latest medical wearables and enabling technologies on the market. Cathy can be contacted at info(at)wearable-technologies.com.